| FLEX |
Report |
Net Sales (Q1 FY27) |
BEAT |
pred ~$7.65B vs. cons $7.52B |
MEDIUM |
| FLEX |
Report |
Adj. EPS - Diluted Operating (Q1 FY27) |
BEAT |
pred ~$0.93 vs. cons $0.907 |
MEDIUM |
| FLEX |
Report |
Adj. Operating Income (Q1 FY27) |
BEAT |
pred ~$505M vs. cons $493M |
MEDIUM |
| FLEX |
Guide |
Net Sales Q2 FY27 (Q2 FY2027) |
BETTER |
guide ~$7.8B vs. cons $7.52B |
MEDIUM |
| FLEX |
Guide |
CPI Revenue FY27 Full Year (FY2027) |
UNCHANGED |
guide maintained 65-75% growth vs. prior guide |
MEDIUM |
| FLEX |
Guide |
Adj. Operating Margin FY27 (FY2027) |
UNCHANGED |
guide maintained 7.0%-7.1% vs. prior guide |
MEDIUM |
| FLEX |
Guide |
Adj. EPS Q2 FY27 (Q2 FY2027) |
BETTER |
guide ~$0.95-$1.00 vs. cons UNVERIFIED |
LOW |
| FLEX |
Return |
Day-1 residual (stock − beta × S&P 500) |
+7.0% |
— |
MEDIUM |
| FLEX |
Return |
5-day cumulative residual |
+8.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — Q2 guide above consensus pulls out-quarter estimates higher; CPI ramp math supports upward revisions over the 5-day window |
MEDIUM |